Education
About Us
Working with TipRanks
Follow Us
Shandong Weigao Group Medical Polymer Co Class H (HK:1066)
:1066
Total Valuation
Shandong Weigao Group Medical Polymer Co has a market cap or net worth of HK$27.86B. The enterprise value is HK$25.10B.
Market CapHK$27.86B
Enterprise ValueHK$25.10B
Share Statistics
Shandong Weigao Group Medical Polymer Co has 4,522,332,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,522,332,000
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Shandong Weigao Group Medical Polymer Co’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 6.75%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)6.75%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee1.03M
Profits Per Employee200.78K
Employee Count12,719
Asset Turnover0.38
Inventory Turnover2.57
Valuation Ratios
The current PE Ratio of Shandong Weigao Group Medical Polymer Co is 13.1. Shandong Weigao Group Medical Polymer Co’s PEG ratio is 2.08.
PE Ratio13.1
PS Ratio1.49
PB Ratio0.82
Price to Fair Value0.82
Price to FCF8.91
Price to Operating Cash Flow9.68
PEG Ratio2.08
Income Statement
In the last 12 months, Shandong Weigao Group Medical Polymer Co had revenue of 13.09B and earned 2.07B in profits. Earnings per share was 0.46.
Revenue13.09B
Gross Profit6.58B
Operating Income2.39B
Pretax Income2.55B
Net Income2.07B
EBITDA3.14B
Earnings Per Share (EPS)0.46
Cash Flow
In the last 12 months, operating cash flow was 2.65B and capital expenditures -598.05M, giving a free cash flow of 2.05B billion.
Operating Cash Flow2.65B
Free Cash Flow2.05B
Free Cash Flow per Share0.45
Dividends & Yields
Shandong Weigao Group Medical Polymer Co pays an annual dividend of HK$0.106, resulting in a dividend yield of 3.84%
Dividend Per ShareHK$0.106
Dividend Yield3.84%
Payout Ratio99.92%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.15
52-Week Price Change1.37%
50-Day Moving Average6.31
200-Day Moving Average5.57
Relative Strength Index (RSI)57.60
Average Volume (3m)17.69M
Important Dates
Shandong Weigao Group Medical Polymer Co upcoming earnings date is Mar 31, 2026, TBA (Confirmed).
Last Earnings DateAug 27, 2025
Next Earnings DateMar 31, 2026
Ex-Dividend DateOct 20, 2025
Financial Position
Shandong Weigao Group Medical Polymer Co as a current ratio of 3.20, with Debt / Equity ratio of 22.87%
Current Ratio3.20
Quick Ratio2.78
Debt to Market Cap0.21
Net Debt to EBITDA-1.14
Interest Coverage Ratio9.56
Taxes
In the past 12 months, Shandong Weigao Group Medical Polymer Co has paid 391.03M in taxes.
Income Tax391.03M
Effective Tax Rate0.15
Enterprise Valuation
Shandong Weigao Group Medical Polymer Co EV to EBITDA ratio is 5.07, with an EV/FCF ratio of 7.27.
EV to Sales1.22
EV to EBITDA5.07
EV to Free Cash Flow7.27
EV to Operating Cash Flow5.71
Balance Sheet
Shandong Weigao Group Medical Polymer Co has HK$9.65B in cash and marketable securities with HK$5.51B in debt, giving a net cash position of HK$4.14B billion.
Cash & Marketable SecuritiesHK$9.65B
Total DebtHK$5.51B
Net CashHK$4.14B
Net Cash Per ShareHK$0.92
Tangible Book Value Per ShareHK$4.45
Margins
Gross margin is 49.35%, with operating margin of 18.23%, and net profit margin of 15.79%.
Gross Margin49.35%
Operating Margin18.23%
Pretax Margin19.51%
Net Profit Margin15.79%
EBITDA Margin24.01%
EBIT Margin17.37%
Analyst Forecast
The average price target for Shandong Weigao Group Medical Polymer Co is HK$6.77, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetHK$6.77
Price Target Upside9.92% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast0.74%
EPS Growth Forecast2.13%